why choose us

First received: July 28, 2022

Clinical Trial: Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Opioid Use Disorder

Study Type: INTERVENTIONAL


Official Title: Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Brief Summary: The goal of this study is to compare two approaches for commencing pharmacotherapy with injectable buprenorphine for opioid use disorder (OUD) among jail inmates: (1) at the time of admission or (2) shortly before release.A sample of eligible inmates with sentences of less than 180 days will be randomly assigned to (1) initiating extended-release buprenorphine (XR-B) treatment at the time of admission (n=80), or (2) initiating XR-B treatment within 30 prior to their scheduled release date (n=80).The groups will be…

Read more